Comparison · NCT07072793-41c63094
Matched Treated: Absence Eligibility vs Matched Untreated: Absence Eligibility: Number of Participants With Presence of Any Absence Records: Matched Participants
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Matched Treated: Absence Eligibility vs Matched Untreated: Absence Eligibility: Number of Participants With Presence of Any Absence Records: Matched Participants. Trial comparisons, record NCT07072793-41c63094. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT07072793-41c63094
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.657 | 0.636 | 0.678 | wilson | |
| Risk in group 2 | 0.697 | 0.676 | 0.717 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0398 | -0.0694 | -0.0102 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.943 | 0.902 | 0.985 | log | |
| Odds ratio, group 1 over group 2 | 0.833 | 0.727 | 0.955 | log | |
| Number needed to treat, for one fewer participant with the outcome on Matched Treated: Absence Eligibility than on Matched Untreated: Absence Eligibility | 25.1 | 14.4 | 98.5 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Matched Treated: Absence Eligibility | Participants who received NMV/r for COVID-19 and were eligible for absence from work, were included in this cohort. This arm contains participants who were matched for pre-defined characteristics and are the matched/ adjusted numbers. | 1,255 | 1,909 | OG000 |
| Group 2 | Matched Untreated: Absence Eligibility | Participants who did not receive any antiviral therapy for COVID-19 and were eligible for absence from work, were included in this cohort. This arm contains participants who were matched for pre-defined characteristics and are the matched/ adjusted numbers. | 1,331 | 1,909 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Number of Participants With Presence of Any Absence Records: Matched Participants
- Description
- Number of participants with presence of any absence records was reported in this outcome measure. Index date was the date of first COVID-19 diagnosis.
- Time frame
From index date to the end of follow-up (maximum follow-up was up to an average of 8.3 months during data observation of approximately 1.5 years); retrospective data collected was evaluated in 0.5 months of this study
- Population
Analysis population included all eligible participants whose data were included and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated) who were eligible for absence from work due to COVID-19. Here, N=numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population).
Source ClinicalTrials.gov
Trial
- Title
- A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe
- NCT number
- NCT07072793
- Phases
- Conditions
- COVID-19 (Coronavirus Disease 2019)
- Interventions
- nirmatrelvir-ritonavir
- Lead sponsor
- Pfizer
- Results first posted
- 2026-01-12
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT07072793?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT07072793-41c63094